These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31991002)

  • 1. Cardiac allograft vasculopathy: Insights on pathogenesis and therapy.
    Lee F; Nair V; Chih S
    Clin Transplant; 2020 Mar; 34(3):e13794. PubMed ID: 31991002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial fat volume is related to the degree of cardiac allograft vasculopathy.
    Roest S; Budde RPJ; Brugts JJ; von der Thüsen J; van Walsum T; Taverne YJHJ; Zijlstra F; Bos D; Manintveld OC
    Eur Radiol; 2023 Jan; 33(1):330-338. PubMed ID: 35986769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
    Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
    J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Iliopoulos DC; Voudris V; Siasos G
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):303-311. PubMed ID: 30657571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences.
    Weis M; Weis M
    Transplantation; 2024 Jun; 108(6):1342-1349. PubMed ID: 37899386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.
    Chih S; Chong AY; Mielniczuk LM; Bhatt DL; Beanlands RS
    J Am Coll Cardiol; 2016 Jul; 68(1):80-91. PubMed ID: 27364054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
    Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy.
    Daud A; Xu D; Revelo MP; Shah Z; Drakos SG; Dranow E; Stoddard G; Kfoury AG; Hammond MEH; Nativi-Nicolau J; Alharethi R; Miller DV; Gilbert EM; Wever-Pinzon O; McKellar SH; Afshar K; Khan F; Fang JC; Selzman CH; Stehlik J
    Circ Heart Fail; 2018 Aug; 11(8):e004759. PubMed ID: 30354559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies.
    Shahandeh N; Parikh RV
    Interv Cardiol Clin; 2023 Apr; 12(2):269-280. PubMed ID: 36922067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.
    Clerkin KJ; Topkara VK; Farr MA; Jain R; Colombo PC; Restaino S; Sayer G; Castillo M; Lam EY; Chernovolenko M; Yuzefpolskaya M; DeFilippis E; Latif F; Zorn E; Takeda K; Johnson LL; Uriel N; Einstein AJ
    J Am Coll Cardiol; 2022 Oct; 80(17):1617-1628. PubMed ID: 36265957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
    Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
    Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.
    Peyster EG; Janowczyk A; Swamidoss A; Kethireddy S; Feldman MD; Margulies KB
    Circulation; 2022 May; 145(21):1563-1577. PubMed ID: 35405081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.